Clinical Trials Directory

Trials / Unknown

UnknownNCT04305535

Impact of an Oligomeric Diet in Intestinal Absorption and Inflammatory Markers in Patients With Crohn Disease

Clinical Trial to Evaluate the Effect of an Oligomeric Oral Nutritional Supplement on the Response in Intestinal Absorption and Inflammation, in Patients With CROHN Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
162 (estimated)
Sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a randomized, multicenter, translational, triple-blind, clinical trial in patients with Crohn's disease, who will be prescribed an oral nutritional supplement to control symptoms in the acute phase and to recover in the remission phase.

Detailed description

Multicentric, parallel, randomized, double blind and controlled clinical-nutritional study of 6 months of intervention and 3 study groups of treatment: Experimental group (peptidic diet with a mix of probiotics); Experimental group with placebo (peptidic diet with a placebo); and Control group (control with a polymeric nutritional oral supplement with a placebo) to evaluate the effect on the nutritional status, inflammatory markers and the intestinal absorption

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPeptidic+ProbioticOligomeric oral nutritional supplement (Bi1 peptidic) and a mix of probiotics * Bifidobacterium animalis subsp. lactis BPL1, * Lactobacillus rhamnosus BPL15, * Lactobacillus rhamnosus CNCM i-4036 * Bifidobacterium longum ES1
DIETARY_SUPPLEMENTPeptidic+PlaceboOligomeric oral nutritional supplement (Bi1 peptidic) and a placebo
DIETARY_SUPPLEMENTPolymeric+PlaceboPolymeric oral nutritional supplement and a placebo

Timeline

Start date
2020-02-13
Primary completion
2021-02-01
Completion
2021-06-01
First posted
2020-03-12
Last updated
2020-03-12

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04305535. Inclusion in this directory is not an endorsement.